Company Filing History:
2 out of 1,575 
1 out of 4 Years Active: 2022
Title: Dong-Young Noh: Innovator in Cancer Biomarkers
Introduction
Dong-Young Noh is a prominent inventor based in Yeongdeungpo-gu, South Korea. He has made significant contributions to the field of cancer research, particularly in the development of biomarkers for breast cancer treatment. His work aims to enhance personalized medicine and improve patient outcomes.
Latest Patents
Dong-Young Noh holds a patent for a biomarker that measures the response and prognosis of triple-negative breast cancer to anticancer agents. This innovative biomarker is designed to predict therapeutic responses and prognosis for patients suffering from this aggressive form of cancer. The patent emphasizes the importance of personalized treatment methods, which can significantly enhance the quality and longevity of patients' lives.
Career Highlights
Throughout his career, Dong-Young Noh has been associated with esteemed institutions such as Seoul National University and the Industry-Academic Cooperation Foundation of Sunchon National University. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Wonshik Han and Han-Byoel Lee. Their collaborative efforts have further advanced the research and development of cancer biomarkers.
Conclusion
Dong-Young Noh's innovative work in cancer biomarkers represents a significant advancement in personalized medicine. His contributions are vital for improving treatment outcomes for patients with triple-negative breast cancer.